Go to Research Activity AreaGo to Staff Member AreaGo to Publications AreaGo to News Area

GENOMICS PERSONNEL


De Bellis Gianluca CV

  De Bellis Gianluca

gianluca.debellis * itb.cnr.it
Institute of Biomedical Technologies, National Research Council
Via Fratelli Cervi N. 93, 20090 Segrate (Milan), Italy
Voice: (+39) 02-26422764
FAX: (+39) 02-26422770

Research Area: Genomics

1987 Degree in Chemistry, cum Laude, from 1989 Researcher at the CNR-ITB, from 2005 Senior Scientist at CNR-ITB, since 2010 Research Director. Dr. De Bellis became Director of the Institute for Biomedical Technologies in 2016. He has obtained over 30 grants on projects focused on DNA analysis from CNR , UE, MIUR, Telethon, Fondazione Cariplo and from Industries. Since 1996 he focused on microarray technology. Later on (2004) he started working on massive sequencing technologies (NGS), being one of the first groups working on that. He has published over 120 papers on international peer-reviewed journals (H-index 37).


 


Battaglia Cristina CV  Battaglia Cristina

cristina.battaglia * unimi.it
University of Milano -
Dipartimento di biotecnologie biomediche e medicina traslazionale (BIOMETRA)
Via Fratelli Cervi N. 93, 20090 Segrate (Milan), Italy
Voice: (+39) 02-26422740
FAX: (+39) 02-26422770

Research Area: Genomics

Education and scientific career: Degree in Biology at the University of Milan (1989); ( 1989-1991) post-doctoral fellowship at Max Planck Institute for Biochemistry, Munich (Germany). (1992-1994) Research fellowship at the Bioengineer Unit of Renal Diseases Laboratory, IRFMN, Bergamo. From 1998 to now Researcher (BIO/10).  Teaching: from 2005 Assistant professor of Biochemistry; Faculty of Medicine, University of Milan. 2000: tutor at Molecular Medicine PhD Training Program of University of Milan. From 2012, she is associate researcher of ITB. CNR, Segrate.  Research activities from 1989-1994 her scientific training has been carried out on different aspects of biomedical research, cell biology, biochemistry of proteins of extracellular matrix and nucleic acid (DNA, RNA).  From 1995, research activity is focused to develop new analytical methods in the field of nucleic acids biochemistry and to improve strategies to screen genetic mutation by using DNA microarray technology and sequencing.  Cooperating with Dr. Gianluca De Bellis group (ITB-CNR, Segrate, Milano, Italy), she is involved in research programs for the application of the microarray technology (and ultra deep sequencing for mutations screening and genes expression profiling, high-density SNP genotyping and copy number profiling in normal and tumor samples.  She has presented the results in several meetings and seminars.  She has contributed for the publication of over 40 papers on international journals (H-index: 20).  Ad hoc reviewer: BMC genomics, BMC cancer; Bionformatics; Nucleic Acid Research, Molecular Cancer.
Current research studies. Her research areas are mainly focused on genomic technology on human cancers (renal carcinoma, leukemia, melanoma cancers and tumor cell lines characterization) and genetic diseases (rare diseases such as congenital hyperinsulinism of infancy) using microarray technology, next generation sequencing technologies, molecular biology and bionformatics.


Bordoni Roberta CV

  Bordoni Roberta

roberta.bordoni * itb.cnr.it
Institute of Biomedical Technologies, National Research Council
Via Fratelli Cervi N. 93, 20090 Segrate (Milan), Italy
Voice: (+39) 02-26422740
FAX: (+39) 02-26422770

Research Area: Genomics

She gained expertise in the next-generation sequencing protocols in several fields of application. Several

whole genome sequences of pathogenes (Acinetobacter) have been generated leading to the identification of

virulence and resistance genetic determinants highly relevant in clinics. Mutational analysis in genetic

diseases on large pools of amplicons has been performed. Recently, has been developed a high-throughput

protein expression and interaction analysis platform that combines ORF selection and deep sequencing to

identify proteins interacting with the enzyme tissue transglutaminase. Finally, the performance of massive

sequencing has been evaluated in detecting very low proportions of minority mutated alleles in chronic

myeloproliferative disorders. She is responsible for research units in two projects supported by Regione

Lombardia and CARIPLO.


 


Cifola Ingrid CV

  Cifola Ingrid

ingrid.cifola * itb.cnr.it
Institute of Biomedical Technologies, National Research Council
Via Fratelli Cervi N. 93, 20090 Segrate (Milan), Italy
Voice: (+39) 02-26422705
FAX: (+39) 02-26422770

Research Area: Genomics

She has been involved in research projects granted by MIUR (COFIN, PRIN, FIRB) and by CARIPLO

foundation. At the moment she is focusing on the application of high-throughput technologies for genomic

characterization of human cancer pathologies, such as renal carcinoma (RCC), melanoma, acute myeloid

leukemia (AML), infant acute lymphoblastic leukemia (Infant ALL) and myelodysplastic syndromes (MDS).

She acquired great experience in the application of Affymetrix and Illumina BeadArray microarray platforms

for whole-genome DNA copy number and LOH analysis, gene expression profiling and methylation analysis,

and of the next-generation Illumina GAIIx sequencer for identification of single nucleotide variants (coupled

with targeted capture systems, either in solido (Nimblegen) or in liquido (Agilent SureSelect)), and for

transcriptomic analysis of gene expression levels, splicing variants and fusion transcripts. Her activity is

documented by 10 publications on international peer-reviewed journals and by many presentations in

national and international meetings.


 


 

Consolandi Clarissa CV

  Consolandi Clarissa

clarissa.consolandi * itb.cnr.it
Institute of Biomedical Technologies, National Research Council
Via Fratelli Cervi N. 93, 20090 Segrate (Milan), Italy
Voice: (+39) 02-26422740
FAX: (+39) 02-26422770

Research Area: Genomics

Laurea degree in Biology on 21/07/2000 (University of Milan), with a thesis on "DNA microarrays technology

applied to mutations and polymorphisms detection", in association with the Institute of Biomedical

Technologies of the National Research Council (CNR – ITB) and following PhD in Molecular Medicine,

Curriculum Genomics&Proteomics on 16/01/2004 (University of Milan) with a thesis on "Development of DNA

Microarrays for Human Single Nucleotide Polymorphisms detection". From February 2009 she has a

permanent position as full-time researcher at CNR – ITB.

She has accumulated a ten years' experience in molecular biology and biotechnology, with particular

attention to the Microarray Technology applied in different fields, such as the biomedical analysis (14, 26),

environmental diagnostics and food analysis (4, 20, 31, 37).

At the moment, she is acquiring experience in the field of massive parallel deep sequencing with the Illumina

sequencing technology using for the whole exome sequencing, the analysis of genetic variation, SNP

discovery and transcriptome analysis. In particular, she is involved in the genomic, epigenetic and

transcriptional analysis in cancer and in the study of microorganisms producing anti-infective molecules, with

particular attention on the adaptation of these innovative technologies to the industrial selection of high

producer strains.


 


Mangano Eleonora CV

  Mangano Eleonora

eleonora.mangano * itb.cnr.it
Institute of Biomedical Technologies, National Research Council
Via Fratelli Cervi N. 93, 20090 Segrate (Milan), Italy
Voice: (+39) 02-26422706
FAX: (+39) 02-26422770

Research Area: Genomics

She gained expertise in binformatics and statistical analysis of gene expression and genotyping data

obtained through Affymetrix microarray experiments in solid tumors and rare diseases. She has been working

to develop a novel computational procedure to identify genomic regions where DNA alterations significantly

overlap to gene expression variations in cancers datasets.


 


Petiti Luca CV

  Petiti Luca

luca.petiti * itb.cnr.it
Institute of Biomedical Technologies, National Research Council
Via Fratelli Cervi N. 93, 20090 Segrate (Milan), Italy
Voice: (+39) 02-26422706
FAX: (+39) 02-26422770

Research Area: Genomics

At ITB he is involved in bioinformatic analyses of next generation sequencing data from Roche 454 and

Illumina Genome Analyzer IIx platforms, focusing on SNVs detection in human disorders (DNA-seq, exome

sequencing) and on bacterial transcriptomes (RNA-seq).


 


 

Pinatel Eva CV Pinatel Eva

eva.pinatel * itb.cnr.it
Institute of Biomedical Technologies, National Research Council
Via Fratelli Cervi N. 93, 20090 Segrate (Milan), Italy
Voice: (+39) 02-26422705
FAX: (+39) 02-26422770

Research Area: Genomics

She obtained the master degree in Molecular Biology at the University of Turin in 2008 and the PhD in Biomedical Sciences and Oncology in 2013 in the same University.
She previously worked at the IRCC of Candiolo (TO) and at the Molecular and Biotechnology Center (TO), gaining experience in micro array gene expression and microRNAs expression analysis in tumor context. Her thesis work focused on prediction (using target reverse gene expression approaches) and biological validation of microRNAs having role in breast cancer progression.
At ITB she works as data analyst of next generation sequencing data from Illumina Genome Analyzer IIx platform. She is now focusing on SNVs detection in exome sequencing data of primary plasma cell leukemias, myelodysplastic syndrome and other human disorders.


 


Rizzi Ermanno CV

  Severgnini Marco

marco.severgnini * itb.cnr.it
Institute of Biomedical Technologies, National Research Council
Via Fratelli Cervi N. 93, 20090 Segrate (Milan), Italy
Voice: (+39) 02-26422706
FAX: (+39) 02-26422770

Research Area: Genomics

In 2003, he obtained a Laurea degree in Biomedical Engineering (Politechnic of Milan), with a final score of

93/100. Since 01/02/2004 he has been working in the Genomic group of the Institute of Biomedical

Technologies of the National Research Council (ITB – CNR), located in Segrate (MI), under the scientific

supervision of dott. Gianluca De Bellis. From 01/02/2004 to 31/10/2006 he held a grant fellowship on research

project "Nanotechnologies". From 22/09/2005 to 22/12/2005, he collaborated as a "honorary fellow" with the

CNTech (Center for NanoTechologies), University of Wisconsin, Madison, WI, USA. From 01/11/2006 to

31/03/2008 he had a fellowship on the research topic "Development of methodologies for DNA molecular

diagnostics, with advanced array technologies and related statistical analyses". From 01/04/2008 to

15/12/2009 he held a non-permanent research position (fixed-term contract, art. 23) on the same research

project as above. Since 16/12/2009 he has a permanent position as a full-time researcher of the same

Institute. He authored 17 scientific publications on international peer-reviewed journals and books.


(For spamming reasons the @ symbol has been subsituted with *)


TOP